SCHOTT PHARMA INH O.N./ DE000A3ENQ51 /
14/06/2024 19:31:47 | Chg. -0.400 | Volume | Bid19:31:50 | Ask19:31:50 | High | Low |
---|---|---|---|---|---|---|
27.300EUR | -1.44% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 28.000 | 27.300 |
GlobeNewswire
01:16
ROSEN, LEADING INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
15/06
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Humana Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
15/06
ROSEN, A LEADING LAW FIRM, Encourages FAT Brands Inc. Investors to Secure Counsel Before Important D...
GlobeNewswire
15/06
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Intel Corporation Investors to Secure Counsel Befor...
GlobeNewswire
15/06
ROSEN, A LEADING NATIONAL FIRM, Encourages Harbor Diversified, Inc. Investors to Secure Counsel Befo...
Newsfile Corp
15/06
ROSEN, A TOP RANKED LAW FIRM, Encourages Autodesk, Inc. Investors to Secure Counsel Before Important...
Newsfile Corp
15/06
TOP RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Secure Counsel Before Important De...
Newsfile Corp
15/06
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Bef...
GlobeNewswire
15/06
GDRX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure...